NCT04806867View on ClinicalTrials.gov

Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia

CompletedOBSERVATIONAL
Enrollment

918

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

July 31, 2020

Conditions
Covid19Inflammatory RheumatismRheumatoid ArthritisSpondyloarthritisInflammatory Arthritis
Interventions
OTHER

SePaRIC-Covid19 cohort

All patients with Chronic Inflammatory Rheumatism who were contacted by telephone as part of the innovative organizational strategy and who did not object to the use of their data.

Trial Locations (1)

87000

Service de Rhumatologie, CHu de Limoges, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT04806867 - Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia | Biotech Hunter | Biotech Hunter